We’re pleased to introduce a new author: Akhilesh Pandey,
Senior Underwriter – Research and Manual Development,
who is based in RGA’s Mumbai office. He has written a
comprehensive and detailed review on the natural history,
pathophysiology, and genetics of hepatitis B.
Dr. Paul Davis, MB.BS (Hons), FRACP, Chief Medical
Officer, RGA Australia and one of RGA’s most experienced
medical directors, presents an erudite perspective on the
evolving clinical definition of myocardial infarction over time
and the implications for insurers providing living benefit
coverage for this condition.
The growing importance of understanding genetics in
cancer is highlighted in an article on the subject by Dr.
John J. Lefebre, BSc (Hons), MD, FRCPC, Medical
Consultant, RGA International. Dr. Lefebre, based in
Toronto, is another highly respected RGA medical director
who in his article describes various types of mutations
associated with multiple cancer types and provides a quick
review of basic genetics.
During 2018, the 20th anniversary year of the Longer Life
Foundation (LLF), we are pleased to bring you another in
the series of interviews with former grant recipients from
Washington University School of Medicine in St. Louis. In
this edition, we profile Stephen T. Oh, M.D., Ph.D. Dr. Oh
specializes in research on myeloproliferative neoplasms,
and he kindly sat down with us to provide insight into these
disorders, which are not uncommonly encountered during
insurance underwriting and claims.
We are also pleased to announce that two new webcasts –
one by Dr. Georgiana Pascutiu, Medical Director, Global
Support Team, and one from Eric Westhus, Ph.D., Data
Scientist, Global Research and Data Analytics – are now
directly accessible to you for viewing at your convenience.
Please see page 27 for details.
In this Issue